Happy Holidays ✨  The Dal Bookstore will be closed for the holidays, Dec. 24-Jan. 2. Our last day of operation before the break will be Monday, Dec. 23rd, closing at 4:30 pm.  
See closure and reopening details »



View Cart

Description:
Control of Communicable Diseases Manual, 21st Edition, is the trusted source for public health professionals on identifying and controlling infectious diseases for over 100 years. The updated edition includes new chapters on SARS-CoV-2, Zika, and many more. This landmark publication is essential to all those in and around public health.


View Cart

Description:
The Sanford Guide to Antimicrobial Therapy 2024 (54th edition)

Sanford Guide helps you make the best infectious diseases treatment decisions, fast.

The book is available in three sizes:
* Library Edition (10pt font)
* Spiral Edition (8pt font, spiral bound, opens flat)
* Pocket Edition (5.5pt font, fits in your lab coat but we also sell a magnifying lens)

With Sanford Guide, you get:
* Clinically actionable, concise answers - we give you exactly what you need to make the best decision in a fast-paced setting.
* Institutionally diverse editorial team by design - not every organization has the same patient population, budget, or processes. We bring perspectives from many medical institutions.

Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians, The Sanford Guide to Antimicrobial Therapy provides convenient, concise, and reliable information.

The book includes a FREE 1-month trial of Sanford Guide All Access, which provides expanded content, interactive tables and tools, and constant updates.

Coverage includes:

Clinical syndromes
* Pathogens
* Bacterial
* Fungal
* Mycobacterial
* Parasitic
* Viral

Anti-infective agents
* Dosing
a. Pediatric adjustments
b. Renal adjustments
* Adverse effects
* Activity
* Pharmacology
* Interactions

Preventative therapy

What's New for 2024

We have updated treatment recommendations throughout this edition based on recent references and guidelines. Drugs approved by the FDA since the last edition are included in various tables throughout the edition. Also, we have removed many older references that have been superseded or are simply no longer necessary.

Major updates include:
* Table 1 - Updated with many changes, as always
* Table 4 - Updated legend to better explain the colors/symbols used to denote activity of antibacterial agents
* Table 5 - Updated based on evolving recommendations for treatment of highly resistant bacteria, especially gram-negatives
* Table 8 - Updated to reflect the new FDA risk categorization as well as available data on antimicrobial use during lactation
* Table 14A - Updated to include recommendations for treatment, prophylaxis and prevention of COVID-19
* Table 16 - Updated to cover all antimicrobials approved for pediatric use
* Table 17A - Updated to include SLED (sustained low efficiency dialysis) dosing
* Table 21 - New table summarizing U.S. Travel Vaccination Recommendations


View Cart

Description:
The Sanford Guide to Antimicrobial Therapy 2024 (54th edition)

Sanford Guide helps you make the best infectious diseases treatment decisions, fast.

The book is available in three sizes:
* Library Edition (10pt font)
* Spiral Edition (8pt font, spiral bound, opens flat)
* Pocket Edition (5.5pt font, fits in your lab coat but we also sell a magnifying lens)

With Sanford Guide, you get:
* Clinically actionable, concise answers - we give you exactly what you need to make the best decision in a fast-paced setting.
* Institutionally diverse editorial team by design - not every organization has the same patient population, budget, or processes. We bring perspectives from many medical institutions.

Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians, The Sanford Guide to Antimicrobial Therapy provides convenient, concise, and reliable information.

The book includes a FREE 1-month trial of Sanford Guide All Access, which provides expanded content, interactive tables and tools, and constant updates.

Coverage includes:

Clinical syndromes
* Pathogens
* Bacterial
* Fungal
* Mycobacterial
* Parasitic
* Viral

Anti-infective agents
* Dosing
a. Pediatric adjustments
b. Renal adjustments
* Adverse effects
* Activity
* Pharmacology
* Interactions

Preventative therapy

What's New for 2024

We have updated treatment recommendations throughout this edition based on recent references and guidelines. Drugs approved by the FDA since the last edition are included in various tables throughout the edition. Also, we have removed many older references that have been superseded or are simply no longer necessary.

Major updates include:
* Table 1 - Updated with many changes, as always
* Table 4 - Updated legend to better explain the colors/symbols used to denote activity of antibacterial agents
* Table 5 - Updated based on evolving recommendations for treatment of highly resistant bacteria, especially gram-negatives
* Table 8 - Updated to reflect the new FDA risk categorization as well as available data on antimicrobial use during lactation
* Table 14A - Updated to include recommendations for treatment, prophylaxis and prevention of COVID-19
* Table 16 - Updated to cover all antimicrobials approved for pediatric use
* Table 17A - Updated to include SLED (sustained low efficiency dialysis) dosing
* Table 21 - New table summarizing U.S. Travel Vaccination Recommendations


View Cart

The publication Anti-infective Guidelines for Community-acquired Infections was developed with input from a mix of health professionals with expertise in several fields and practising in a variety of clinical settings. In addition, hundreds of health professionals have provided comments on various editions and this has helped create a very practical and relevant document. We sincerely thank all reviewers for their input and ongoing support.

This publication can be used as a complementary, educational tool, focusing primarily on managing community-acquired infections and when necessary assisting in the selection of appropriate antibiotics.